Partners in the fight against malaria: malaria today
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.
Learn more
Related news and resources
Navigating the ECOWAS Joint Assessment Procedure
The ECOWAS Joint Assessment Procedure is a collaborative initiative among 15 National Regulatory Agencies in West Africa that ensures harmonized and streamlined market authorization of medical products across the region. This infographic provides an overview of key steps and timelines applicants need to bear in mind during the Joint Assessment Procedure.
Read more
Innovative pharmaceutical industry contributes to discussions on universal health coverage and health security during 76th World Health Assembly
On 30 May, IFPMA issued a statement summarizing their contributions to universal health coverage and health security at the 76th World Health Assembly.
Read moreIndividual statement at WHA76 on agenda items 13.1 and 13.2
On 26 May, IFPMA provided a WHA76 statement on agenda items 13.1: Reorienting health systems to primary health care as a resilient foundation for universal health coverage and preparations for a high-level meeting of the United Nations General Assembly on universal health coverage and 13.2: Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, and mental health.
Read more